FavId

Related by string. Favier . Favis . Favi * * coach Binky Favis . Binky Favis . candidate FavId . Ms. Nelly Favis . Jaap Favier *

Related by context. All words. (Click for frequent words.) 74 Specifid 71 trastuzumab DM1 T DM1 70 PDX pralatrexate 69 MAGE A3 ASCI 69 FOLOTYN ® 68 PANVAC VF 68 MyVax R 68 MOZOBIL 67 CoFactor 67 Personalized Immunotherapy 67 refractory chronic lymphocytic 67 Onco TCS 67 pralatrexate 67 Xcellerated T Cells 66 SinuNase TM 66 Xcytrin R 66 Dacogen injection 66 Evoltra ® 66 Soliris TM eculizumab 66 Phase #b/#a clinical 66 vosaroxin 66 galiximab 66 SAR# [004] 66 subcutaneous formulation 66 oral ridaforolimus 66 Panzem R NCD 66 LEUKINE 65 L BLP# 65 Traficet EN 65 HuMax CD4 65 PEG SN# 65 Azedra 65 phase IIb clinical 65 ONTAK 65 phase IIa clinical 65 oncolytic virus therapies 65 OvaRex R 65 alvespimycin 65 YONDELIS 65 TELCYTA 65 tanespimycin 65 HCD# [002] 65 IL# PE#QQR 65 sorafenib tablets 65 Hematide ™ 65 Entereg R 65 lorvotuzumab mertansine 64 ThermoDox ® clinical 64 Aryplase 64 investigational monoclonal antibody 64 ZEVALIN 64 OvaRex ® MAb 64 XL# anticancer compounds 64 Panzem R 64 CINTREDEKIN BESUDOTOX 64 PrevOnco 64 TELINTRA 64 Omigard 64 Telintra 64 tramiprosate Alzhemed TM 64 BLA submission 64 severe hypercholesterolemia 64 INTEGRILIN R eptifibatide Injection 64 PI3K/Akt pathway inhibitor 64 Chemophase 64 Veronate 64 SYCREST 64 PXD# 64 Solazed 64 GRNVAC1 64 hoFH 64 Marqibo 64 Clolar ® 64 thalidomide Thalomid 64 lucinactant 64 EDEMA3 63 EFAPROXYN 63 UPLYSO 63 Aurexis 63 refractory gout 63 Phase IIIb clinical 63 BEXXAR 63 #D#C# 63 forodesine 63 BrachySil TM 63 LEP ETU 63 MAA submission 63 Civacir 63 Alocrest 63 lenalidomide Revlimid R 63 Cinryze ™ 63 CRMD# 63 registrational 63 OncoVEX 63 elotuzumab 63 ofatumumab HuMax CD# 63 Bezielle 63 previously untreated follicular 63 Viramidine 63 Telatinib 63 PEG PAL 63 Fibrillex TM 63 ongoing Phase 1b 63 HspE7 63 Fodosine 63 PrevOnco ™ 63 Entereg TM 63 mocetinostat MGCD# 63 MGCD# [001] 63 Allovectin 7 63 ZEVALIN ® 63 HepeX B 63 thymalfasin 63 Archexin 63 talactoferrin 63 FUSILEV ® 63 pradefovir 63 dacetuzumab 63 interferon gamma 1b 63 Virulizin ® 63 Targretin 63 midstage clinical 63 Phase 1b trial 63 pegloticase 63 Anturol 63 candidate AQ4N 63 CR# vcMMAE 63 Corlux 63 picoplatin 63 ALN PCS 63 Genasense ® 63 phase IIb III 63 cutaneous T 63 targeted radiotherapeutic 63 FOLOTYN 63 TLK# 63 EOquin 63 TBC# 63 IMGN# 63 R sorafenib tablets 63 Phenoptin 62 EVIZON TM squalamine lactate 62 Allovectin 7 R 62 BrachySil 62 MyVax ® 62 relapsed refractory multiple myeloma 62 Myocet 62 AzaSite Plus 62 TOCOSOL Paclitaxel 62 ALN TTR# 62 TRISENOX ® 62 vaccines oncolytic virus 62 Arzerra TM 62 GVAX ® 62 cancer immunotherapies 62 enzastaurin 62 balsalazide tablet 62 confirmatory Phase III 62 SPRYCEL ® 62 EOquin TM 62 chemotherapy induced neutropenia 62 peginesatide 62 Plicera 62 Liprotamase 62 mertansine 62 SinuNase 62 Anturol ® 62 Onalta 62 Anturol TM 62 CD# antibody [001] 62 PLK1 SNALP 62 elacytarabine 62 ELACYT 62 Exelixis compounds 62 r hGH 62 oral proteasome inhibitor 62 PNP inhibitor 62 Xanafide 62 ruxolitinib 62 ADVEXIN 62 Cleviprex TM clevidipine 62 Urocidin 62 oral methylnaltrexone 62 ENABLE Phase 2 62 KRYSTEXXA TM pegloticase 62 StaphVAX R 62 docetaxel Taxotere ® 62 valopicitabine 62 NEBIDO 62 ganetespib 62 ponatinib 62 Canvaxin TM 62 Thalomid ® 62 Phase Ib 62 NEUMUNE 62 BAY #-# 62 markets HP Acthar 62 SILENOR TM 62 ZOLINZA 62 R#/MEM # 62 Triapine R 62 humanized anti 62 GALNS 62 acyclovir Lauriad R 62 relapsed multiple myeloma 62 Virulizin R 62 Dyloject TM 62 sNDAs 62 Zenvia ™ 62 oral prodrug 62 octreotide implant 62 lintuzumab SGN 62 Oracea TM 62 Pegasys ® 62 Rhucin ® 62 Fibrin Pad 62 BLA filing 62 OHR/AVR# 62 leading oral taxane 62 Cloretazine ® 62 Crofelemer budesonide foam 62 Zemiva TM 62 hypoxia activated prodrug 62 docetaxel Taxotere R 62 amrubicin 62 OncoVEX GM CSF 62 azficel T 62 BiovaxID 62 MGd 62 VitiGam 62 Romiplostim 62 STEDESA 62 Amrubicin 62 JAK inhibitor 62 including eniluracil ADH 62 INCB# [002] 62 TRANSDUR Sufentanil 62 Exelbine 62 G#DT 62 IMA# 62 L MTP PE 61 Phase Ib II 61 Fx #A 61 Zemiva ™ 61 Ceflatonin R 61 albinterferon alfa 2b 61 CA9 SCAN 61 Bicifadine 61 vernakalant oral 61 Junovan 61 StaphVAX 61 INTEGRILIN ® 61 phase III isavuconazole 61 lomitapide 61 Fludara ® 61 HEPLISAV 61 PRTX 61 UVIDEM 61 Phase Ib study 61 tolevamer 61 Sulonex TM 61 dirucotide 61 LymphoStat B 61 Epratuzumab 61 oral antiviral 61 oxypurinol 61 Cellegesic 61 Asentar 61 ISTODAX 61 Daclizumab 61 AEG# 61 Targretin capsules 61 ridaforolimus 61 custirsen 61 GAMMAGARD 61 Iluvien ® 61 DEB# 61 erlotinib Tarceva ® 61 Trofex ™ 61 Solazed TM 61 ATPace TM 61 Combidex 61 adecatumumab MT# 61 ZADAXIN 61 BLP# Liposome Vaccine 61 GTC recombinant human 61 ALN TTR 61 Onconase 61 TRIOLEX HE# APOPTONE HE# 61 Troxatyl 61 rThrombin 61 Vitaxin 61 Somatuline R Autogel R 61 CD# CEA 61 PEG INTRON R 61 TACI Ig 61 histamine dihydrochloride 61 Panzem 61 CD# monoclonal antibody 61 AGGRASTAT R 61 DXL# 61 Neo Kidney Augment 61 TKM ApoB 61 Androxal TM 61 HEPLISAV TM 61 romiplostim 61 Telavancin 61 Lauren Silvernail 61 PRECISE trial 61 Nexavar ® 61 TNFerade 61 ATryn ® 61 generation purine nucleoside 61 investigational antiplatelet agent 61 T Pred 61 TYZEKA 61 Tarceva TM 61 Tovaxin ® 61 candidate TNFerade biologic 61 SILENOR 61 Canvaxin 61 Amigal 61 IND submission 61 rhThrombin 61 THALOMID 61 AQ4N 61 telaprevir VX 61 HGS ETR1 61 XL# XL# 61 Phase 2b clinical 61 budesonide foam 61 FACTIVE R gemifloxacin 61 TKM PLK1 61 bardoxolone 61 huC# DM4 61 nalbuphine ER 61 Rhucin ® recombinant 61 Acute Radiation Syndrome ARS 61 voreloxin 61 NP2 Enkephalin 61 MKC# MT 61 Generx TM 61 candidate REP# 61 romidepsin 61 VISICOL R 61 IoGen 61 diagnostic radiopharmaceutical 61 Triolex 61 Actimmune ® 61 forodesine hydrochloride 61 ixabepilone 61 hA# 61 Phase Ib clinical trials 61 lumiliximab 61 Poly ICLC 61 Gemzar ® 61 Revimmune 61 Genasense ® oblimersen 61 Besivance 61 Amoxicillin PULSYS 61 MAXY G# 61 Phase IIb clinical trials 61 hyaluronidase enzyme 61 sapacitabine CYC# 61 anti CD# antibodies 61 celgosivir 61 P#X# antagonist 61 lintuzumab 61 KALBITOR ® 61 paclitaxel Taxol R 61 huN# DM1 61 Phase #/#a trial 61 vidofludimus 61 AGGRASTAT ® 61 dasatinib Sprycel ® 61 modified glutathione analog 61 Shigamabs ® 61 HQK 61 RITUXAN 61 Ceplene TM 61 Trofex 61 JOULFERON 61 Phase #/#a 61 Firazyr 61 Campath ® 60 CIP ISOTRETINOIN 60 Icatibant 60 Alinia 60 Linjeta TM 60 rituximab Rituxan 60 Phase IIa trials 60 rindopepimut 60 PROVENGE ® 60 Pivotal Phase III 60 Cloretazine 60 paclitaxel Taxol ® 60 StemEx R 60 tiapamil 60 intravenous methylnaltrexone 60 CCX# 60 Dacogen 60 SinuNase ™ 60 vivo toxicology 60 Onalta ™ 60 intravenous acetaminophen 60 MGCD# [002] 60 torsemide ER 60 Phase IIb III 60 ZEGERID Powder 60 Proxinium TM 60 Allovectin 7 r 60 BioNumerik 60 tamibarotene 60 eTag assays 60 pomalidomide 60 AzaSite Xtra 60 MAXY alpha 60 Eculizumab 60 IMPDH inhibitor 60 proteasome inhibitor 60 oral taxane 60 RIGScan CR 60 maribavir 60 PSMA ADC 60 Pralatrexate 60 HGS ETR2 60 lesinurad 60 candidate CRLX# 60 visilizumab 60 XL# XL# XL# XL# 60 Asentar TM 60 Neuradiab 60 HepeX B TM 60 Cloretazine R VNP#M 60 Iluvien TM 60 MEPACT 60 incyclinide 60 Cintredekin Besudotox 60 Tectin TM 60 BrachySil ™ 60 Annamycin 60 GSK# [002] 60 Urocidin TM 60 Allovectin 7 ® 60 virus HCV protease inhibitor 60 Navelbine ® 60 Initiate Clinical Trial 60 StemEx 60 budesonide MMX 60 MOVIPREP R 60 ORENCIA ® 60 alvimopan 60 Neulasta R 60 Belinostat 60 inhaled AAT 60 IMiDs 60 ZEGERID Capsules 60 sodium thiosulfate STS 60 GEM OS2 60 REOLYSIN ® 60 Clolar 60 urocortin 2 60 DR Cysteamine 60 Ceflatonin 60 MEND CABG II 60 treatment naive genotype 60 Plenaxis R 60 aflibercept 60 CD3 monoclonal antibody 60 INTEGRILIN 60 Phase Ib clinical 60 Leukine 60 HepaGam B 60 Pegloticase 60 glufosfamide 60 Azedra TM 60 telbivudine 60 DAVANAT 60 BRIM2 60 ORENCIA R 60 RhuDex TM 60 AVASTIN 60 panitumumab Vectibix 60 Genentech Rituxan 60 herpetic keratitis 60 ecallantide 60 NUEDEXTA ™ 60 RAPTIVA 60 ALN VSP 60 methylnaltrexone bromide 60 omega interferon 60 zanolimumab 60 adecatumumab 60 dextromethorphan quinidine 60 Prestara 60 tafamidis 60 compound PMX # 60 Golimumab 60 ofatumumab 60 HGS# 60 ONCASPAR 60 oritavancin 60 XL# XL# XL# 60 Acetavance TM 60 telomerase inhibitor drug 60 vapreotide acetate 60 Phase IIa clinical trials 60 INCB# [001] 60 EmbraceAC 60 initiate Phase 1b 60 MYDICAR 60 IV Busulfex 60 2 methoxyestradiol 60 EGS# 60 Actilon 60 Quinamed 60 IV APAP 60 BiovaxID TM 60 reslizumab 60 Theratope 60 Nabi HB Intravenous 60 Ketotransdel 60 BARACLUDE R 60 Hedgehog Pathway Inhibitor 60 rALLy clinical trial 60 Romidepsin 60 Xeloda ® 60 AMD# [002] 60 oral talactoferrin 60 Zelrix 60 ularitide 60 Locteron 60 CAMPATH 60 Elagolix 60 Ixempra 60 methylnaltrexone 60 ANTEGREN 60 Alzhemed TM 60 FOLFOX6 chemotherapy regimen 60 Soliris eculizumab 60 recurrent metastatic ovarian cancer 60 IAP inhibitors 60 KNS # 60 NUVIGIL 60 DPX Survivac 60 GVAX R 60 pentadentate logo R 60 Pradefovir 60 Alvesco R 60 MGN# 60 BACcel 60 CALGB # [002] 60 registrational trial 60 platforms GVAX 60 sipuleucel T 60 Zybrestat 60 initiated Phase 1b 60 Ecallantide 60 Voraxaze ™ 60 Phase III clinical 60 Catena ® 60 TOCOSOL Camptothecin 60 Ereska 60 Phase 2a trial 60 Cinryze TM 60 Difimicin 60 TRISENOX 60 bafetinib 60 Zelapar 60 Velcade bortezomib 60 Somatuline Depot 60 ZACTIMA 60 Acetavance 60 omacetaxine 60 nonclinical studies 60 TRISENOX R 60 etanercept Enbrel 60 ® bortezomib 60 opioid induced bowel dysfunction 60 Azixa 60 Vicinium TM 60 randomized multicenter Phase III 60 Biological License Application 60 personalized cellular immunotherapy 60 Acute Radiation Syndrome 60 Phase #b/#a 60 Genitope Corporation 60 cetuximab Erbitux ® 60 Gliadel Wafer 60 isavuconazole 60 personalized immunotherapy 60 carfilzomib 60 evaluating Actimmune 59 OncoGel 59 THR beta agonist 59 highly purified pasteurized 59 marketed pegylated interferons 59 Albugon 59 Genasense R oblimersen 59 mapatumumab 59 dacetuzumab SGN 59 individualized cellular immunotherapy 59 PIX# trial 59 Puricase PEG uricase 59 Lucanix R 59 Evoltra 59 BENLYSTA ® 59 gemcitabine Gemzar ® 59 BR.# 59 mocetinostat 59 Apoptone 59 deforolimus 59 alemtuzumab MS 59 hematological cancers 59 IgG1 monoclonal antibody 59 Trastuzumab 59 obatoclax 59 relapsed MM 59 Prednisporin 59 Nebido 59 Intravenous CP 59 rNAPc2 59 Leukine ® 59 Phase III Pivotal 59 eniluracil 59 Riquent 59 bevacizumab Avastin ® 59 miconazole Lauriad 59 Budesonide MMX 59 oral picoplatin 59 Azedra ™ 59 kidney urologic 59 POSIDUR TM 59 Phase III randomized controlled 59 Pivotal Phase 59 cell lymphoma CTCL 59 Sulonex 59 PREOS R 59 REVLIMID R 59 Simulect 59 Prestara TM 59 ThermoDox R 59 Aganocide 59 prGCD 59 Exherin TM 59 alfa 2a 59 IONSYS TM 59 APTIMA HPV assay 59 carcinoid syndrome 59 TORISEL 59 oxymorphone ER 59 BRILINTA 59 Medidur TM FA 59 HuMax TAC 59 torezolid phosphate 59 phase Ib 59 systemic RNAi therapeutic 59 Vaxfectin TM 59 Phase III TRIST 59 AAG geldanamycin analog 59 Hybridon 59 cetuximab Erbitux R 59 Telik logo TELINTRA 59 cutaneous T cell 59 NVA# 59 non nucleoside inhibitor 59 taliglucerase alfa 59 XL# SAR# 59 Augment TM 59 arsenic trioxide injection 59 casopitant 59 Dacetuzumab 59 HCV protease inhibitor 59 ATryn R 59 Rhucin R 59 cangrelor 59 Fludara 59 Evoltra R 59 GLASSIA 59 faropenem 59 SNS# T 59 IV acetaminophen 59 INSPIRE Trial Phase III 59 GSK# [001] 59 Panzem NCD 59 CINQUIL 59 ELADUR 59 granted Ortec 59 YERVOY 59 investigational immunotherapy 59 pseudobulbar affect PBA 59 Cloretazine R 59 ospemifene 59 Phase IIb trials 59 telomerase therapeutic 59 Zerenex 59 ONCONASE R 59 phase IIb trial 59 mifamurtide 59 candidate deforolimus 59 LibiGel ® testosterone gel 59 VIBATIV 59 Levoleucovorin 59 liposomal formulation 59 proprietary Capillary Aerosolization Technology 59 investigational hepatitis B 59 Fast Track Status 59 MGCD# MGCD# [001] 59 clevudine 59 LibiGel ® 59 CHOP chemotherapy 59 midstage trials 59 Hematide TM 59 Phase 2b Clinical Trial 59 palifosfamide 59 Pyridorin 59 Plenaxis TM 59 catheter occlusion 59 FOLFOX chemotherapy 59 Pemetrexed 59 Tarmogen 59 Rescula 59 successfully commercialize Iluvien 59 indiplon capsules 59 TREANDA 59 Dalbavancin 59 M Vax 59 Vion Pharmaceuticals 59 Zingo TM 59 Elotuzumab 59 multicenter Phase III 59 INC# 59 Urocortin 2 59 radiation sensitizer 59 Stimuvax R 59 GED aPC 59 Phase Ib IIa 59 CEQ# 59 RSD# oral 59 docetaxel chemotherapy 59 velafermin belinostat 59 TRANSDUR ® 59 Campath alemtuzumab 59 OPAXIO 59 Perforomist ™ Inhalation Solution 59 please visit www.advaxis.com 59 ADVEXIN clinical 59 LymphoStat B TM 59 TroVax 59 refractory Hodgkin lymphoma 59 Cardio Vascu Grow 59 Pirfenidone 59 multiple myeloma MM 59 MyVax 59 pharmacogenomic translational research 59 VALSTAR 59 phase IIb 59 Altastaph 59 cannabinor 59 anidulafungin 59 Ventavis 59 Alseres Cethrin 59 orally administered inhibitor 59 Sunesis Pharmaceuticals 59 rALLy trial 59 daptomycin 59 IMiDs ® compound 59 MAb therapy 59 Increlex R 59 Aflibercept 59 ALN HPN 59 Harbor BioSciences 59 XP# XP# 59 EVIZON TM 59 Empatic ™ 59 veltuzumab 59 NEUVENGE 59 LEVADEX ™ 59 Abiraterone acetate 59 ENRICH trial 59 Sebivo 59 Omacetaxine 59 Anthim 59 Phase III Trial 59 CANCIDAS 59 Accentia Biopharmaceuticals 59 NDA Submission 59 MT# MEDI 59 Insegia 59 Azedra TM Onalta TM 59 autologous cellular immunotherapy 59 XOMA 3AB 59 Advaxis Phase 59 Phase 2a clinical trials 59 PORxin TM platforms 59 OLEPTRO TM 59 EGRIFTA TM 59 bortezomib Velcade 59 CYCLOSET 59 MYCAMINE 59 Prednisporin TM 59 PRT# 59 novel therapeutic antibodies 59 Treanda 59 standard chemotherapy regimen 59 Augment Injectable 59 Cimzia TM 59 IMC #B 59 Topical Interferon Alpha 2b 59 Phase 2b study 59 Hyphanox 59 cinacalcet HCl 59 5 lipoxygenase inhibitor 59 delivers fluocinolone acetonide FA 59 relapsed refractory aggressive 59 belinostat 59 sodium Injection 59 lapatinib Tykerb 59 Xelox 59 ketolide antibiotic 59 mitomycin 59 systemic anaplastic large 59 pralatrexate injection folate analogue 59 Reolysin 59 depsipeptide 59 EV# vaccine 59 PROSTASCINT R 59 severe hypersensitivity reactions 59 novel histone deacetylase 59 Capesaris 59 Increlex TM 59 systemically administered 59 MyVax personalized immunotherapy 59 small molecule chemotherapeutic 59 Curaxin CBLC# 59 RH1 targeted chemotherapeutic agent 59 Gabapentin GR 59 SUMAVEL 59 OAB overactive bladder 59 CLIRS trial 59 postoperative ileus POI 58 Aplidin R 58 next generation URAT1 58 Kosan dependence 58 histone deacetylase HDAC inhibitor 58 ARIKACE ™ 58 vaginally administered lidocaine 58 erlotinib Tarceva R 58 perifosine 58 treat chronic sinusitis 58 trastuzumab Herceptin R 58 refractory multiple myeloma 58 Tamibarotene 58 ViaCyte 58 PROMACTA 58 Neuromodulation System 58 Phase IIB 58 Genasense 58 Vidaza R 58 Cimzia R 58 Ambrisentan 58 Acetavance TM intravenous acetaminophen 58 anti CD3 monoclonal 58 LymphoStat B belimumab 58 Mepact 58 DASISION 58 zileuton CR 58 Taxotere ® 58 CYT# potent vascular disrupting 58 AERx iDMS 58 ONCONASE 58 orBec 58 ILUVIEN ® 58 Tovaxin TM 58 recombinant PSMA vaccine 58 Deferiprone 58 confirmatory clinical 58 Vectibix panitumumab 58 dextofisopam 58 Prodarsan R 58 REVLIMID lenalidomide 58 Zavesca R 58 dose escalation clinical 58 Sular formulation 58 EGFr expressing metastatic colorectal 58 lupus nephritis 58 DC Bead 58 phase Ib clinical 58 DIFICID ™ 58 IIa trial 58 commercialize ZYFLO CR 58 Oracea 58 Tengion Neo Urinary Conduit 58 TYGACIL 58 low dose cytarabine 58 AMEVIVE 58 Aloxi injection 58 Arzerra ofatumumab 58 molecular imaging radiopharmaceutical 58 plus DOXIL 58 lexidronam injection 58 eltrombopag 58 Pruvel 58 Proellex TM 58 Oncophage 58 Matrix Phase 2b 58 PNT# 58 Phase IIa clinical 58 esophageal candidiasis 58 DOS# 58 blinded randomized placebo controlled 58 Maxy G# 58 NEUPOGEN 58 cancer neuroendocrine tumor 58 human C1 inhibitor 58 Oral NKTR 58 #I TM# 58 EndoTAG TM -1 58 cintredekin besudotox 58 Diamyd ® 58 Cardium Therapeutics TM 58 Eraxis 58 pan HDAC inhibitor 58 ocrelizumab 58 rALLy 58 budesonide MMX Phase III 58 non nucleoside HCV 58 Veronate R 58 peginterferon alfa 58 PROVENGE sipuleucel T 58 confirmatory Phase 3 58 Ontak 58 bortezomib Velcade R 58 GVAX 58 ATL# [001] 58 FUSILEV 58 clinical trials dacetuzumab SGN 58 Revimmune TM 58 Immunotherapeutic 58 Metastatic Melanoma 58 BEMA TM Fentanyl 58 lupus renal disease 58 Phase 1b clinical 58 bicifadine 58 volociximab 58 multicenter Phase II 58 Thelin TM 58 Sudhir Agrawal D.Phil 58 visit www.targanta.com 58 AzaSite TM 58 Restanza 58 tubulin inhibitor 58 PROPEL trial 58 Clonicel 58 NPSP# 58 Files Investigational 58 GLP toxicology studies 58 adalimumab Humira 58 APF# 58 vinorelbine tartrate 58 Hepatocellular Carcinoma HCC 58 Inhalation Solution 58 sargramostim 58 CTAP# Capsules 58 FDA Approvable Letter 58 BRAF inhibitor 58 pharmacokinetic PK study 58 MabThera rituximab 58 XmAb# 58 Tovaxin 58 Trofex TM 58 IRX 2 58 TNFerade TM 58 ZYBRESTAT 58 alemtuzumab Campath 58 Increlex ® 58 cystinosis patients 58 satraplatin 58 micafungin 58 ACAPODENE TM 58 OraTest R 58 Marketing Authorization Application 58 blinatumomab 58 S1P antibody 58 Aclidinium 58 Stedivaze 58 NeuroSTAT ® 58 LUNESTA TM 58 HYVISC R 58 Zolinza 58 Phase #b/#a trial 58 PROSTVAC TM 58 Oncaspar 58 intravesical infusion therapy 58 Glufosfamide 58 PMA submission 58 Saforis 58 cell malignancies 58 Initiate Phase

Back to home page